Browse the corpus

The Controlled Substance Act (CSA) establishes a federal policy to regulate the manufacturing, distribution, importation, exportation, and use of regulated substances. The CSA lays the framework for categorizing controlled substances and creates a legal foundation for their regulation. This statute was an effort to combine all previous federal drug laws and allow for federal law enforcement of controlled substances, serving as the legal foundation in the federal fight against drug abuse. The cornerstone of the CSA is the classification system by which it regulates controlled substances. This system has 5 schedules of these drugs, numbered I through V. The CSA stratifies these based on a substance’s accepted medical use, potential abuse/addiction, and harmfulness. This activity highlights the categorization schedules, amendments, prescription requirements, and other pertinent factors for interprofessional team members to understand and apply the legal structure to their clinical practice. Objectives: Identify the key provisions and regulations outlined in the US Controlled Substances Act that impact medical and pharmacy practice. Differentiate between the different schedules of controlled substances and the corresponding requirements for handling, prescribing, and dispensing each category. Apply the US Controlled Substances Act knowledge to document and maintain controlled substance prescribing, administration, and dispensing records. Implement proper procedures in compliance with the US Controlled Substances Act to securely store, handle, and distribute controlled substances within medical and pharmacy settings. Access free multiple choice questions on this topic.

Title II of the Comprehensive Drug Abuse Prevention and Control Act of 1970, commonly known as the Controlled Substance Act (CSA), establishes a federal policy to regulate the manufacturing, distributing, importing/exporting, and use of regulated substances.[1] The CSA was enacted by the 91st United States Congress and signed into law by President Richard Nixon in 1970.[2] This statute was an effort to combine all previous federal drug laws and allow for federal law enforcement of controlled substances, serving as the legal foundation in the federal fight against drug abuse. Initially, the purpose of the CSA was to fulfill the requirements of 2 international treaties, the Single Convention on Narcotic Drugs (1961) and the Convention on Psychotropic Substances (1971).[2] These 2 treaties created a classification system in accordance with the scientific and medical findings of public health authorities. Under the 2 international treaties, the public health authority referenced is the World Health Organization, and under the CSA, it is the Secretary of Health and Human Services (HHS).[2]

The entire interprofessional healthcare team, including physicians, advanced practice practitioners, nursing staff, pharmacists, and pharmacy techs, form a network of checks and balances, all looking to ensure the safety of patients regarding controlled substances that are prescribed and dispensed. A team-centered approach to identifying risk factors, monitoring pain symptoms, and thoroughly assessing patients for chronic pain is the ideal way to limit complications. The team approach can include evaluating pain symptoms by primary providers, including multidisciplinary pain modalities (including physical/occupational therapy, recreational therapy, and cognitive behavioral therapy), evaluation of medication regimen by pharmacists, and inclusion of pain medicine specialists. Prescribers (physicians, physicians' assistants, and nurse practitioners), nurses, and pharmacists can also monitor for adverse effects of controlled substances. Open lines of communication and shared decision-making among all interprofessional team members can provide care coordination for optimal pain management.